NGL FINECHEM
Back to Income Statement
|
NGL FINECHEM Last 5 Year Total Expenditure History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Expenditure | ₹285 Cr | ₹243 Cr | ₹249 Cr | ₹178 Cr | ₹13,192,719 Cr |
What is the latest Total Expenditure of NGL FINECHEM ?
Year | Total Expenditure |
---|---|
Mar2025 | ₹285 Cr |
Mar2024 | ₹243 Cr |
Mar2023 | ₹249 Cr |
Mar2022 | ₹178 Cr |
Mar2021 | ₹13,192,719 Cr |
How is Total Expenditure of NGL FINECHEM Trending?
Years | Total Expenditure | % Change | |
---|---|---|---|
Mar2025 | ₹285 Cr | 17.20 | |
Mar2024 | ₹243 Cr | -2.48 | |
Mar2023 | ₹249 Cr | 40.17 | |
Mar2022 | ₹178 Cr | -100.00 | |
Mar2021 | ₹13,192,719 Cr | - |
Compare Total Expenditure of peers of NGL FINECHEM
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NGL FINECHEM | ₹817.0 Cr | 7.6% | 7% | -50.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹390,864.0 Cr | -4.3% | -3% | -0.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹168,811.0 Cr | -3.3% | -7.4% | 34.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹124,352.0 Cr | 1.4% | 10.1% | 17.9% | Stock Analytics | |
CIPLA | ₹121,260.0 Cr | -4.4% | -0.5% | 0.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,786.0 Cr | -5.2% | -5.7% | -5.9% | Stock Analytics |
NGL FINECHEM Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NGL FINECHEM | 7.6% |
7% |
-50.9% |
SENSEX | -1.1% |
-3.4% |
-1.1% |
You may also like the below Video Courses